Other

Sanofi to buy US biotech firm Amunix for $1 bn

French pharma giant Sanofi said Tuesday it had signed a billion-dollar deal to buy US-based biotech firm Amunix, which develops cancer treatments that enlist the body's immune system.

Vaccination

Left-behind Sanofi closes in on Covid vaccine

French pharmaceuticals giant Sanofi on Monday reported positive results in trials of its belated Covid-19 jab, raising hopes that France can finally make up lost ground after falling behind in the race to develop a vaccine.

Vaccination

Sanofi and GSK to provide 72 million vaccine doses to Canada

French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their COVID-19 vaccine candidate to the Canadian government, which has already signed similar agreements with several American companies.

Diseases, Conditions, Syndromes

Sanofi expands US vaccine venture in COVID-19 race

French pharmaceutical giant Sanofi said Tuesday that it would invest $425 million to expand its vaccine development venture with US start-up Translate Bio as they aim to find a COVID-19 vaccine by next year.

Other

Coronavirus boosts sales for French pharma giant Sanofi

French pharmaceutical giant Sanofi said Friday that its first quarter sales surged in part due to stockpiling of the painkiller Doliprane, as other companies around the world struggle during the coronavirus pandemic.

Medications

Sanofi says charged in birth defects case

Pharmaceutical firm Sanofi has been charged in France with failure to adequately warn patients and causing injury over an anti-epilepsy drug linked to birth defects following a three-year probe.

page 8 from 13